Bertholletia excelsa

Bertholletia excelsa has been studied in 2 papers since 2022: 1 trial in people, 1 review; 1 in the past year. The newest paper, Feb 11, 2026: “Supplementation with mixed nuts does not improve inflammatory biomarkers or dietary inflammatory potential in post-myocardial infarction: a secondary analysis of the DICA-NUTS trial”.

Intervention

2 papers study it2 findingsUpdated

See all 2 papers on bertholletia excelsa

At a glance

The findings reach people, from one lab or study. 1 lab in 1 country.

None of its findings points the other way.

Humans: a single group. Cells, worms or flies and mice: nothing yet.
  • 1 lab in 1 country
  • Funders: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior and 2 more
  • Human trial1

What did studies of bertholletia excelsa find?

2

Studies of bertholletia excelsa measured 2 outcomes: cognitive function and fasting glucose.

Cognitive function

upin humans1

1 study
  1. Bertholletia excelsa improves cognitive function in older adults with mild cognitive impairment.

    “Older adults with mild cognitive impairment improved verbal fluency and constructional praxis”

    Reviewin older adults with mild cognitive impairment

    Effects of Regular Brazil Nut (Bertholletia excelsa H.B.K.) Consumption on Health: A Systematic Review of Clinical Trials

    Foods (Basel, Switzerland)

Fasting glucose

downin humans1

1 study
  1. Bertholletia excelsa decreases fasting glucose in healthy subjects.

    “In addition, healthy subjects improved lipid markers and fasting glucose.”

    Reviewin healthy subjects

    Effects of Regular Brazil Nut (Bertholletia excelsa H.B.K.) Consumption on Health: A Systematic Review of Clinical Trials

    Foods (Basel, Switzerland)

More on Fasting glucose

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 1Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 01 paper in 12 months